
 PsychRounds: The Psychiatry Podcast
 PsychRounds: The Psychiatry Podcast Alprazolam (Xanax)
 9 snips 
 Oct 29, 2025  This discussion dives into the history of Xanax, tracing its approval for anxiety and panic in the '80s. The hosts explore its rapid effects on the GABA-A receptor and highlight safety concerns, including addiction and withdrawal risks. They emphasize its suitable use for acute anxiety rather than long-term treatment. Intriguingly, they touch on its potential antidepressant effects and regulatory challenges, including a denied depression indication. Comparative efficacy against other medications offers more insight into its role in anxiety management. 
 AI Snips 
 Chapters 
 Transcript 
 Episode notes 
Rapid Onset And Short Half-Life
- Alprazolam is fast-acting with onset as quick as 15 minutes and peak plasma at 1–2 hours.
- It has high lipid solubility, a 10–12 hour half-life, and is metabolized primarily by CYP3A4.
Prefer PRN Dosing And Conservative Start
- Start adults at 0.25–0.5 mg up to three times daily and observe the FDA max of 4 mg/day.
- Prefer PRN dosing to minimize long-term dependence and withdrawal risk.
High Potency And Rapid Dependence
- One milligram of alprazolam roughly equals 10 mg of diazepam, reflecting high potency.
- Rapid onset and short duration make tolerance, reinforcement, and severe withdrawal more likely within weeks.
